{
    "2019-12-09": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Flagging French Drug Giant Tries a Familiar Remedy",
                "features": {
                    "keywords": [
                        "French",
                        "Drug",
                        "Giant",
                        "Remedy"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-16",
                "original_text": "Sanofi’s New CEO Is Aiming for a Narrower Focus in Drug Development",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "CEO",
                        "Narrower",
                        "Focus",
                        "Drug",
                        "Development"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-17",
                "original_text": "Biotech stocks are producing outsized gains — here’s how to get your share",
                "features": {
                    "keywords": [
                        "Biotech",
                        "stocks",
                        "outsized",
                        "gains"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-18",
                "original_text": "Amgen Gets FDA Approval for J&J/Merck's Remicade Biosimilar",
                "features": {
                    "keywords": [
                        "Amgen",
                        "FDA",
                        "Approval",
                        "J&J/Merck",
                        "Remicade",
                        "Biosimilar"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}